1. Routine invasive management early after fibrinolysis: Relationship between baseline risk and treatment effects in a pooled patient-level analysis of 7 randomized controlled trials 
Akshay Bagai, MD, MHS, Mary Tan, MSc, Carlo Di Mario, MD, Sigrun Halvorsen, MD, PhD, Warren J. Cantor, MD, Michel R. Le May, MD, Francisco Fernandez-Aviles, MD, Bruno Scheller, MD, Paul W. Armstrong, MD, Francesco Borgia, MD, Federico Piscione, MD, Pedro L. Sánchez, MD, Cynthia M. Westerhout, PhD, Shaun G. Goodman, MD, MSc, Andrew T. Yan, MD 
American Heart Journal 
Volume 168, Issue 5, Pages e3 (November 2014)
DOI: /j.ahj
Copyright © 2014 Elsevier Inc. Terms and Conditions

2. Figure 1
Kaplan-Meier curves for 30-day outcomes. A, Kaplan-Meier curves for death/re-MI at 30days. B, Kaplan-Meier curves for death at 30days. C, Kaplan-Meier curves for re-MI at 30days.
American Heart Journal  , e3DOI: ( /j.ahj )
Copyright © 2014 Elsevier Inc. Terms and Conditions

3. Figure 2
Treatment effect of routine early invasive strategy in relation to baseline risk stratified by trial. There was no heterogeneity in treatment efficacy by baseline risk observed across the individual trials (P for interaction=.91).
American Heart Journal  , e3DOI: ( /j.ahj )
Copyright © 2014 Elsevier Inc. Terms and Conditions